ENG-002

N/A

Report date: 2024/12/18 13:39:48

NME

Base Information

Drug NameENG-002

Drug Alias NameENG-002

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGamma-aminobutyric acid A receptor alpha-2 modulatorsGamma-aminobutyric acid A receptor alpha-3 modulatorsGamma-aminobutyric acid A receptor alpha-5 modulators +[4]

TargetsGamma-aminobutyric acid A receptor alpha-2Gamma-aminobutyric acid A receptor alpha-3Gamma-aminobutyric acid A receptor alpha-5 +[4]

Therapy Area/IndicationsPainMuscle Spasticity

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesEngrail Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesEngrail Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsPainMuscle Spasticity

Inactive IndicationsN/A

Other Information

ATC CodeN/A